Want to join the conversation?
$CF 2Q15 Q&A: Zekauskas of JPMorgan asked about cost of the $500MM in synergies. Tony said, on cost to achieve it, there are transaction cost associated with the deal, there is IT and integration cost going forward; lot of those are year one impact and run rate synergies are going to kick in from that. Transaction cost would be typical for the deal
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?